Pattern of Buprenorphine Treatment Retention Among Youth Aged 10 to 18 Years—US, 2015 to 2021, in JAMA Pediatrics
key takeaway: "Youth who initiated buprenorphine treatment in 2016 were retained in treatment longer than those who began treatment in other years. Policy changes in the Comprehensive Addiction and Recovery Act of 20166 and the COVID-19 pandemic may have impacted prescription practices and accessibility of services. Approximately 82% of youth had only 1 treatment episode."
Comments